A National Survey Exploring Dementia Diagnostics and Care Provisions in Primary Care in England

Dementia is a condition that slowly erodes memory and thinking, affecting millions of people and their families across the world. In England, the number of people living with a formal diagnosis has been rising steadily, making it the leading cause of death in the country. For decades, the path to understanding this condition has usually started at a local doctor's office, where a patient first mentions memory lapses. From there, the journey often leads to specialist clinics for confirmation, after which care typically returns to the local doctor for long-term management. Now, a new chapter is opening. Medical science is on the verge of introducing powerful new treatments that can slow the disease's progress, alongside advanced blood tests that can detect it earlier. These changes promise to transform care, but they also demand a massive shift in how the healthcare system operates, moving more responsibility from large hospitals back into the community.

This shift is the focus of a recent national survey conducted by researchers in England. The team wanted to understand the reality on the ground: are local doctors ready to handle these new tools and treatments? They asked general practitioners, the doctors who see patients daily, about their current practices and their hopes for the future. The survey was designed with input from doctors, policy experts, and people who have lived experience with dementia, ensuring the questions mattered to everyone involved. The researchers reached out to doctors across five different regions of England, covering cities, towns, and rural areas, to get a broad picture of the situation.

The results reveal a system that is currently stretched thin but willing to adapt if given the right support. Almost every doctor surveyed uses standard cognitive tests and blood work to help identify dementia, yet fewer than half can directly order brain scans, which are often necessary for a clear picture. Currently, most doctors act as a gateway, referring patients to specialist memory clinics for a formal diagnosis. When looking ahead five years, the majority of these doctors do not expect to take over the formal diagnosis of dementia themselves. They cite a lack of confidence, insufficient training, and a shortage of time as the main barriers. The complexity of the condition, which can mimic other health issues, makes them hesitant to make the call without specialist backup.

However, there is a glimmer of optimism regarding the new technologies. Many doctors feel they could easily incorporate blood tests for biomarkers—substances in the blood that signal the disease—into their routine, provided they have the funding and access. This would allow them to gather solid evidence to support a diagnosis right in their own clinics. When it comes to the new disease-modifying treatments, the outlook is more cautious. Most doctors do not believe they will be assessing patients for eligibility for these drugs in the near future, viewing that role as belonging to specialists. Yet, many expressed a willingness to prescribe or monitor these medications if clear shared agreements were in place with specialists, similar to how other complex conditions are managed today.

The survey highlights that while the medical community sees the value in bringing more care closer to home, the current infrastructure is not quite ready. Doctors reported that they already spend a significant amount of time reviewing the health of patients with dementia, checking their mental state, medications, and physical well-being. They work closely with community groups and social care services to support patients after a diagnosis. But for the system to truly shift from hospitals to local neighborhoods, the researchers found that doctors need more than just a change in policy. They need protected time, extensive training, and a reimagined relationship between local practices and specialist hospitals. Without these resources, the promise of earlier detection and better treatment risks becoming a burden rather than a breakthrough for the doctors who stand at the front line of care.